NSYS · Nortech Systems Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $30.32M | - | $30.48M | $30.68M | $26.89M | - | $31.41M | $33.89M | $34.22M | - |
| Cost of Revenue | $25.61M | - | $25.46M | $25.84M | $23.82M | - | $27.57M | $29.27M | $28.77M | - |
| Gross Profit | $4.70M | - | $5.03M | $4.84M | $3.08M | - | $3.83M | $4.62M | $5.45M | - |
| R&D | $310.0K | - | $266.0K | $302.0K | $326.0K | - | $284.0K | $291.0K | $318.0K | - |
| SG&A | $3.01M | - | $2.59M | $2.59M | $2.92M | - | $2.95M | $2.98M | $3.17M | - |
| Total Operating Expenses | $4.66M | - | $4.08M | $4.09M | $4.69M | - | $4.30M | $4.27M | $4.29M | - |
| D&A | $347.0K | - | - | - | $342.0K | - | - | - | $482.0K | - |
| Operating Income | $47.0K | - | $945.0K | $742.0K | ($1.61M) | - | ($467.0K) | $344.0K | $1.16M | - |
| Interest Expense | $256.0K | - | $273.0K | $257.0K | $167.0K | - | $130.0K | $165.0K | $167.0K | - |
| Income Tax | ($175.0K) | - | $818.0K | $172.0K | ($511.0K) | - | $56.0K | $22.0K | $223.0K | - |
| Net Income | ($34.0K) | - | ($146.0K) | $313.0K | ($1.32M) | - | ($739.0K) | $157.0K | $765.0K | - |
| EPS - Basic | ($0.01) | - | ($0.05) | $0.12 | ($0.48) | - | ($0.27) | $0.06 | $0.28 | - |
| EPS - Diluted | ($0.01) | - | ($0.05) | $0.12 | ($0.48) | - | ($0.27) | $0.05 | $0.26 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.96M | $1.66M | $1.27M | $652.0K | $1.16M | $916.0K | $1.24M | $1.54M | $4.03M | $960.0K |
| Accounts Receivable | $17.82M | $17.00M | $18.81M | $17.81M | $15.67M | $14.88M | $16.58M | $17.58M | $16.05M | $19.28M |
| Inventory | $23.56M | $20.70M | $18.43M | $18.63M | $20.91M | $21.64M | $22.33M | $22.79M | $22.95M | $21.66M |
| Accounts Payable | $14.64M | $12.81M | $11.68M | $11.93M | $10.06M | $11.58M | $12.31M | $12.73M | $15.22M | $15.92M |
| Current Assets | $60.67M | $56.15M | $59.21M | $58.32M | $57.32M | $55.31M | $60.28M | $59.16M | $59.12M | $58.79M |
| Total Assets | $76.64M | $71.92M | $74.76M | $74.83M | $73.53M | $72.44M | $76.97M | $76.26M | $75.45M | $75.13M |
| Current Liabilities | $33.00M | $29.84M | $33.60M | $21.61M | $20.72M | $21.43M | $23.32M | $23.30M | $25.72M | $26.58M |
| Long-term Debt | $2.20M | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $41.93M | $37.37M | $41.40M | $41.44M | $40.70M | $38.43M | $41.28M | $40.11M | $39.45M | $39.78M |
| Stockholders' Equity | $34.71M | $34.55M | $33.36M | $33.39M | $32.83M | $34.01M | $35.69M | $36.15M | $36.01M | $35.34M |
| Retained Earnings | $17.09M | $17.12M | $16.23M | $16.37M | $16.06M | $17.38M | $18.85M | $19.59M | $19.43M | $18.67M |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($1.56M) | - | - | - | ($2.93M) | - | - | - | $2.83M | - |
| Investing Cash Flow | ($228.0K) | - | - | - | ($268.0K) | - | - | - | ($735.0K) | - |
| Financing Cash Flow | $2.34M | - | - | - | $3.45M | - | - | - | $274.0K | - |
| CapEx | $228.0K | - | - | - | $268.0K | - | - | - | $744.0K | - |
| Free Cash Flow | ($1.79M) | - | - | - | ($3.20M) | - | - | - | $2.08M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 15.5% | - | 16.5% | 15.8% | 11.4% | - | 12.2% | 13.6% | 15.9% | - |
| Operating margin | 0.2% | - | 3.1% | 2.4% | -6.0% | - | -1.5% | 1.0% | 3.4% | - |
| EBITDA margin | 1.3% | - | - | - | -4.7% | - | - | - | 4.8% | - |
| Net margin | -0.1% | - | -0.5% | 1.0% | -4.9% | - | -2.4% | 0.5% | 2.2% | - |
| Free cash flow margin | -5.9% | - | - | - | -11.9% | - | - | - | 6.1% | - |
| FCF / Net income | 52.62 | - | - | - | 2.43 | - | - | - | 2.72 | - |
| R&D / Revenue | 1.0% | - | 0.9% | 1.0% | 1.2% | - | 0.9% | 0.9% | 0.9% | - |
| SG&A / Revenue | 9.9% | - | 8.5% | 8.4% | 10.8% | - | 9.4% | 8.8% | 9.3% | - |
| Effective tax rate | - | - | 121.7% | 35.5% | - | - | - | 12.3% | 22.6% | - |
| Return on assets | -0.0% | - | -0.2% | 0.4% | -1.8% | - | -1.0% | 0.2% | 1.0% | - |
| Return on equity | -0.1% | - | -0.4% | 0.9% | -4.0% | - | -2.1% | 0.4% | 2.1% | - |
| Return on invested capital | 0.1% | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 1.84 | 1.88 | 1.76 | 2.70 | 2.77 | 2.58 | 2.59 | 2.54 | 2.30 | 2.21 |
| Quick ratio | 1.12 | 1.19 | 1.21 | 1.84 | 1.76 | 1.57 | 1.63 | 1.56 | 1.41 | 1.40 |
| Cash ratio | 0.06 | 0.06 | 0.04 | 0.03 | 0.06 | 0.04 | 0.05 | 0.07 | 0.16 | 0.04 |
| Leverage | ||||||||||
| Debt / Equity | 0.06 | - | - | - | - | - | - | - | - | - |
| Debt / Assets | 0.03 | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | 5.58 | - | - | - | - | - | - | - | - | - |
| Interest coverage | 0.2x | - | 3.5x | 2.9x | -9.7x | - | -3.6x | 2.1x | 6.9x | - |
| Equity multiplier | 2.21 | 2.08 | 2.24 | 2.24 | 2.24 | 2.13 | 2.16 | 2.11 | 2.10 | 2.13 |
| Liabilities / Assets | 0.55 | 0.52 | 0.55 | 0.55 | 0.55 | 0.53 | 0.54 | 0.53 | 0.52 | 0.53 |
| Efficiency | ||||||||||
| Asset turnover | 0.40 | - | 0.41 | 0.41 | 0.37 | - | 0.41 | 0.44 | 0.45 | - |
| Inventory turnover | 1.09 | - | 1.38 | 1.39 | 1.14 | - | 1.23 | 1.28 | 1.25 | - |
| Days sales outstanding | 215d | - | 225d | 212d | 213d | - | 193d | 189d | 171d | - |
| Days inventory outstanding | 336d | - | 264d | 263d | 320d | - | 296d | 284d | 291d | - |
| Days payable outstanding | 209d | - | 167d | 169d | 154d | - | 163d | 159d | 193d | - |
| Cash conversion cycle | 342d | - | 322d | 307d | 379d | - | 325d | 315d | 269d | - |
| Valuation | ||||||||||
| P / E | - | - | - | 74.4x | - | - | - | 273.0x | 51.3x | - |
| P / B | 1.0x | - | 0.8x | 0.8x | 0.8x | - | 0.9x | 1.1x | 1.1x | - |
| P / S | 1.1x | - | 0.8x | 0.9x | 1.0x | - | 1.0x | 1.2x | 1.1x | - |
| EV / EBITDA | 86.8x | - | - | - | - | - | - | - | 21.3x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 12.7% | - | -2.9% | -9.5% | -21.4% | - | -5.9% | -3.2% | -1.9% | - |
| Revenue CAGR (3y) | -4.6% | - | -4.8% | -1.9% | -4.3% | - | 2.2% | 3.9% | 15.7% | - |
| Revenue CAGR (5y) | 6.6% | - | 2.9% | 3.0% | -0.4% | - | 0.9% | 4.4% | 4.0% | - |
| Gross profit growth (YoY) | 52.8% | - | 31.0% | 4.8% | -43.5% | - | -27.9% | -15.7% | -0.7% | - |
| Operating income growth (YoY) | - | - | - | 115.7% | - | - | - | -68.7% | 9.7% | - |
| Net income growth (YoY) | 97.4% | - | 80.2% | 99.4% | - | - | - | -75.2% | 12.3% | - |
| EPS growth (YoY) | 97.9% | - | 81.5% | 140.0% | - | - | - | -77.3% | 13.0% | - |
| EPS CAGR (3y) | - | - | - | -21.7% | - | - | - | -5.9% | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | 44.1% | - | - | - | - | - | - | - | 70.5% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 5.7% | 1.6% | -6.5% | -7.6% | -8.8% | -3.8% | 16.2% | 22.6% | 24.6% | 25.9% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Product / service
$89.53M totalMedical Imaging$31.91M · 35.6%
Medical Device$22.36M · 25.0%
Industrial$22.15M · 24.7%
Aerospace And Defense$13.11M · 14.6%
Peer comparison
Same SIC group: Electronic Components, NEC
Comparing NORTECH SYSTEMS INC against the 5 most active filers in the same SIC group.